Increasing Access to Biosimilars Act of 2020

House Bill 6179 - Increasing Access to Biosimilars Act of 2020: Overview, Status, and Impact

Hozzl · 2022-02-08T23:17:33Z

Explore the details of House Bill 6179 Increasing Access to Biosimilars Act of 2020 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/8/2022, 11:17 PM

Congressional Summary of HR 6179

Increasing Access to Biosimilars Act of 2020

This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6179

Bill HR 6179 is currently in the status of Bill Introduced since March 10, 2020. Bill HR 6179 was introduced during Congress 116 and was introduced to the House on March 10, 2020. Bill HR 6179's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 10, 2020

Bipartisan Support of Bill HR 6179

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6179

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight

- Government studies and investigations

- Health care costs and insurance

- Medicare

- Prescription drugs

Alternate Title(s) of Bill HR 6179

Increasing Access to Biosimilars Act of 2020

To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.

Increasing Access to Biosimilars Act of 2020